Transition from hemifusion to pore opening is rate limiting for vacuole membrane fusion. by Reese, C. & Mayer, A.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 171, No. 6, December 19, 2005 981–990
http://www.jcb.org/cgi/doi/10.1083/jcb.200510018
 
JCB: ARTICLE
 
JCB 981
 
Transition from hemifusion to pore opening is rate 
limiting for vacuole membrane fusion
 
Christoph Reese and Andreas Mayer
 
Département de Biochimie, Université de Lausanne, 1066 Epalinges, Switzerland
 
usion pore opening and expansion are considered
the most energy-demanding steps in viral fusion.
Whether this also applies to soluble 
 
N
 
-ethyl-male-
imide sensitive fusion protein attachment protein receptor
(SNARE)– and Rab-dependent fusion events has been un-
known. We have addressed the problem by characteriz-
ing the effects of lysophosphatidylcholine (LPC) and other
late-stage inhibitors on lipid mixing and pore opening
during vacuole fusion. LPC inhibits fusion by inducing
positive curvature in the bilayer and changing its bio-
physical properties. The LPC block reversibly prevented
F
 
formation of the hemifusion intermediate that allows lipid,
but not content, mixing. Transition from hemifusion to
pore opening was sensitive to guanosine-5
 

 
-(
 

 
-thio)tri-
phosphate. It required the vacuolar adenosine triphos-
phatase V
 
0
 
 sector and coincided with its transformation.
Pore opening was rate limiting for the reaction. As with vi-
ral fusion, opening the fusion pore may be the most energy-
demanding step for intracellular, SNARE-dependent fusion
reactions, suggesting that fundamental aspects of lipid
mixing and pore opening are related for both systems.
 
Introduction
 
Protein-mediated fusion reactions are sensitive to membrane
lipid composition (Chernomordik and Kozlov, 2003). Lipids
such as phosphoinositides control the activity and concentra-
tion of fusion proteins (Simonsen et al., 2001). Lipids also di-
rectly influence bilayer mixing via their biophysical properties,
i.e., charge and conformation, which determine the spontaneous
curvature of membranes (Chernomordik et al., 1997). A physical
influence on the membrane may also form the basis for effects of
phosphatidylethanolamine on p97/p47–mediated Golgi–liposome
fusion (Pecheur et al., 2002) and of cholesterol and sphingolip-
ids, which are required for fusion of Semliki forest virus (Ahn
et al., 2002).
Lysophosphatidylcholines (LPCs) exhibit positive spon-
taneous curvature (Fuller and Rand, 2001). They inhibit fusion
of protein-free bilayers (Chernomordik et al., 1995; Wu et al.,
1996), viral fusion (Chernomordik et al., 1997; Melikyan et al.,
2000), exocytosis (Vogel et al., 1993), and microsome fusion
(Chernomordik et al., 1993). LPCs show increasing inhibitory
potency with increasing hydrocarbon chain length (Cherno-
mordik et al., 1997), and they show equivalent effects in different
fusion systems using very different proteinaceous machines.
Therefore, LPCs probably act via lipid conformation and
membrane curvature rather than by direct influence on fusion-
relevant proteins.
Consequently, a universal physical intermediate of all
bilayer fusion reactions was postulated that should be indepen-
dent of the protein machinery inducing fusion and cannot be
overcome in the presence of LPC. This intermediate may be a
fusion stalk (Chernomordik and Zimmerberg, 1995; Kozlovsky
et al., 2002; Chernomordik and Kozlov, 2003). In a stalk, the
outer leaflets of two fusing bilayers are merged, whereas the
inner leaflets remain separated. The stalk is a structure of nega-
tive membrane curvature. It can expand into a hemifusion state
in which lipids from the inner monolayers associate to produce
a new bilayer, the hemifusion diaphragm. Hemifusion is detect-
able for viral fusion systems, particularly if the normal fusion
pathway is disturbed (Kemble et al., 1994; Melikyan et al.,
1995, 2005; Chernomordik et al., 1998; Munoz-Barroso et al.,
1998). It can also be generated in the polyethylene glycol–,
hypotonic stress–, and cation-induced fusion of liposomes
(Chanturiya et al., 1997; Lee and Lentz, 1997; Meers et al.,
2000). Also, SNARE-dependent fusion can generate hemifu-
sion states. Depending on the conditions, these can be unpro-
ductive alternative outcomes or intermediates on the pathway
to full fusion (Giraudo et al., 2005; Lu et al., 2005; Reese et al.,
2005; Xu et al., 2005).
Homotypic fusion of yeast vacuoles is a model reaction
of SNARE-dependent intracellular fusion for which a cell-free
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fusion assay is available (Mayer, 2002; Wickner, 2002). Vacu-
ole fusion proceeds in several steps and depends on numerous
proteins. In brief, the following events are relevant to this
study: priming is characterized by the ATP-dependent rear-
rangements of SNAREs, GTPases, and tethering factors and is
a prerequisite for subsequent steps. cis-SNARE complexes are
disassembled by the ATPase Sec18p/NSF and its cofactor
Sec17p/
 

 
-SNAP, which is released from the vacuole (Mayer et
al., 1996; Ungermann et al., 1998a). The second step, mem-
brane attachment, requires the Rab-GTPase Ypt7p and leads to
the formation of trans-SNARE complexes between the fusion
partners (Mayer and Wickner, 1997; Ungermann et al., 1998b).
Trans-SNARE pairing triggers a measurable release of cal-
cium from the vacuole (Peters and Mayer, 1998; Merz and
Wickner, 2004b). V
 
0
 
, the membrane integral part of the vacuolar
H
 

 
-ATPase, is required to complete fusion (Peters et al., 2001;
Bayer et al., 2003; Thorngren et al., 2004).
In this study, we have modulated bilayer conformation by
LPC and explored the effects on the fusion pathway of yeast
vacuoles. The assay of lipid perturbation promises important
insights into the fusion mechanism, such as the timing of bi-
layer merger and factors required to induce it. We performed a
kinetic analysis to map the LPC-sensitive step and correlated
these data to molecular marker events for docking and post-
docking events in order to determine the rate-limiting stage of
vacuole fusion.
 
Results
 
LPCs inhibit in vitro fusion of yeast 
vacuoles
 
In vitro fusion of yeast vacuoles recapitulates the in vivo fusion
of these organelles but provides accessibility to low and high
molecular weight inhibitors. The reaction can be traced by a
content-mixing assay relying on transfer of a lumenal vacuolar
protease between the fusion partners. Vacuoles are prepared
from two strains. One strain (BJ3505) expresses pro-alkaline
phosphatase (ALP) in its vacuoles, and the other (DKY6281)
expresses the respective maturation enzyme proteinase A.
Upon fusion between the vacuoles, proteinase A from one vac-
uole can mature pro-ALP from the other fusion partner and ac-
tivate it. The resulting enzymatic activity can be assayed by
spectrophotometry. It serves as a quantitative readout of fusion.
We investigated the effects of LPC on vacuole fusion by
titrating LPCs of different acyl chain lengths into fusion reac-
tions. LPCs spontaneously incorporate into lipid bilayers. They
lack the fatty acid at the sn-C2 position of the glycerol back-
bone, conferring an inverted cone shape. At the C1 position,
different fatty acids can be attached via ester linkages. We
tested 1-caprylyl, 1-capryl, 1-lauroyl, and 1-myristoyl LPCs,
carrying saturated fatty acids with 8, 10, 12, or 14 carbon at-
oms, respectively. All LPCs inhibited the fusion of yeast vacu-
oles (Fig. 1 A). The IC
 
50
 
 values increased from 30 
 

 
M for
LPC-14 (1-myristoyl-2-hydroxy-sn-glycero-3-phosphocholine)
to 3 mM for LPC-8 (1-caprylyl-2-hydroxy-sn-glycero-3-phos-
phocholine), depending on the hydrocarbon chain length of the
respective LPC. A similar trend was reported for influenza HA
fusion (Chernomordik et al., 1997). This suggests that LPCs
inhibit vacuole fusion and viral fusion by the same principle.
Because the proteins involved in both reactions are very differ-
ent, LPCs most likely inhibit via a structural influence on the
lipid bilayer rather than a deleterious effect on a fusion protein.
Recently, Thorngren et al. (2004) found that addition of
the recombinant t-SNARE subunit Vam7p (rVam7p) leads to
the accumulation of excess trans-SNAREs and renders vacuole
fusion independent of several early acting components, such
as ATP and Sec18p/NSF-mediated priming. LPC suppressed
rVam7p-mediated fusion (Fig. 1 B), suggesting that it acts on a
late step of vacuolar membrane fusion.
 
LPCs block vacuole fusion after 
vacuole docking
 
The latest reaction phase blocked by an inhibitor can be inferred
from the kinetics with which the reaction becomes insensitive
to the inhibitor. In such an experiment, a fusion reaction is
Figure 1. LPC inhibits vacuole fusion. (A) Titration of four different LPCs.
Standard fusion reactions were incubated at 27C in the presence of the
indicated inhibitors at increasing concentrations. One sample was kept on
ice. After 70 min, fusion activity was assayed. Values were normalized to
the controls without inhibitors, and ice values were subtracted. The means
of five independent experiments are shown with SD. Fusion activity in the
positive controls varied from 2.29 to 5.45 U. (B) LPC and Vam7p in vacu-
ole fusion. Standard fusion reactions were supplemented with 420 M
LPC-12 and 300 nM of purified recombinant Vam7p (rVam7) as indicated
and incubated on ice for 10 min. An ATP-regenerating system or buffer
was added, and fusion was started by incubating samples at 27C. After
70 min, fusion activity was determined. The means  SD of four independent
experiments is shown.
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incubated at 27
 

 
C. At certain time points, aliquots are removed,
supplemented either with buffer (control; no change in the final
fusion activity should be observed) or with inhibitor, and incu-
bated further at 27
 

 
C until the end of a standard 70-min reac-
tion period. Progression of an uninhibited reaction is monitored
by transferring one aliquot to 0
 

 
C at every time point. This
stops the reaction. The ice curve is indicative of fusion pore
opening because there is no significant delay between contents
mixing and the processing of the reporter pro-ALP (Merz and
Wickner, 2004a). The reaction became insensitive to antibody
inhibition of the priming ATPase Sec18p/NSF within 15 min
(Mayer et al., 1996; Fig. 2). Gdi1p (guanine nucleotide disso-
ciation inhibitor), which binds and partially extracts the Rab-
GTPase Ypt7p from the membrane (Mayer and Wickner,
1997) and thereby blocks docking, inhibited up to 30 min.
Inhibitors blocking the reaction between docking and fusion
pore opening, such as the chelator 1,2-bis-(o-aminophenoxy)-
ethane-N,N,N
 

 
,N
 

 
-tetraacetic acid (BAPTA) and guanosine-5
 

 
-
(
 

 
-thio)triphosphate (GTP
 

 
S), yield inhibition curves between
those of Gdi1p and ice (Mayer et al., 1996; Peters and Mayer,
1998; Peters et al., 1999; Reese et al., 2005). LPC-14 and -12
showed such inhibition kinetics. The time courses for both in-
hibitors overlapped, suggesting that they affect the same late
step of the reaction and act by the same mechanism. Because
LPCs inhibit other fusion systems at the lipid-mixing stage
(Chernomordik et al., 1998; Melikyan et al., 2000), this result
suggests that lipid mixing is kinetically distinguishable from
docking and significantly precedes contents mixing.
The analysis in the preceding paragraph does not rule out
the possibility that LPCs additionally inhibit earlier reaction
steps. Therefore, we scored molecular marker events for priming
and docking. Priming separates vacuolar cis-SNARE com-
plexes through the action of Sec18p/NSF and Sec17p/
 

 
-SNAP
(Ungermann et al., 1998a). As a consequence, Sec17p/
 

 
-SNAP
is released from the vacuole into the supernatant (Mayer et al.,
1996). We tested the influence of LPC-14 and -12 on Sec17p/
 

 
-SNAP release (Fig. 3). The vacuolar membrane protein ALP
was blotted as a control for complete separation of membranes
and supernatant. When vacuoles were incubated under fusion
conditions without an ATP-regenerating system, Sec17p/
 

 
-
SNAP remained associated with the vacuoles (Fig. 3). After
addition of an ATP-regenerating system, Sec17p/ 
 

 
-SNAP was
released into the supernatant within 15 min. Antibodies to
NSF/Sec18p inhibited this reaction, whereas the docking inhib-
itor Gdi1p did not influence it. Neither LPC-14 nor -12 blocked
Sec17p release.
Docking results in the trans-association of v- and t-SNAREs
from opposing membranes. The in vitro fusion reaction of yeast
vacuoles offers the opportunity to assay this association and to
determine whether trans-SNARE pairing correlates to fusion
activity (Ungermann et al., 1998a,b; Merz and Wickner,
2004b). To this end, vacuoles are prepared from strains ex-
pressing only the vacuolar t-SNARE Vam3p or the v-SNARE
Nyv1p. After mixing these two populations of vacuoles and
incubating them in the presence of postdocking inhibitors of
fusion, the membranes are diluted and solubilized. The trans-
association of v- and t-SNAREs can then be assayed by coim-
munoprecipitation of the v-SNARE Nyv1p with antibodies to
the t-SNARE Vam3p. In the absence of a fusion inhibitor, these
complexes represent a mixture of three species: trans-SNARE
complexes between vacuoles that did not complete fusion; trans-
SNARE complexes converted into cis-SNARE complexes be-
cause they triggered successful fusion of the vacuoles; and
cis-SNARE complexes formed independently of docking by
reassociation of solitary v- and t-SNAREs subsequent to the
completion of fusion, i.e., as a simple result of membrane mix-
ing between the v- and t-SNARE–carrying membranes. In the
Figure 2. Time course of inhibition by LPC. 10 standard fusion reac-
tions were started. 10 min before the indicated time points, 30-l aliquots
were supplemented with 1.5 l of the indicated inhibitors or of buffer and
placed on ice for 10 min. At the indicated time points, the samples were
returned to 27C and incubated until the end of the total reaction period
of 70 min. One sample was kept on ice for each time point. The means of
four independent experiments normalized to the controls are shown with SD.
Fusion activity varied between 3.52 and 5.5 U. The following inhibitors
were used: 0.3 M anti-Sec18p antibody, 1 M Gdi1p, 650 M LPC-12,
and 140 M LPC-14.
Figure 3. Priming in the presence of LPC. 3 standard fusion reactions
without ATP-regenerating system were preincubated with the indicated in-
hibitors (5 min, 0C). The ATP-regenerating system or control buffer was
added, and reactions were started by incubation at 27C. The sample
without ATP was kept on ice. After 15 min, the reactions were stopped by
chilling on ice. 1 ml PS buffer with 150 mM KCl was added, and vacuoles
were sedimented (21,000 g, 3 min, 4C). 900 l of the supernatant was
transferred to a new reaction tube, TCA precipitated, and analyzed by SDS-
PAGE and Western blotting. Vacuole pellets were resuspended in 200 l of
fusion buffer with 150 mM KCl, transferred to a new reaction tube, and cen-
trifuged (21,000 g, 3 min, 4C). Pellets were analyzed by SDS-PAGE and
Western blotting. The following inhibitors were used: 0.3 M anti-Sec18p
antibody, 1 M Gdi1p, 500 M LPC-12, and 120 M LPC-14.
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presence of late-acting fusion inhibitors, only the first species
should accumulate. We tested for the formation of trans-
SNARE complexes in the presence of LPCs. Without an ATP-
regenerating system, priming and docking cannot occur and no
Nyv1p could be coimmunoprecipitated with Vam3p (Fig. 4). In
the presence of ATP, SNARE complexes formed. Simulta-
neous addition of the docking inhibitor Gdi1p completely
blocked the formation of SNARE complexes, indicating that
they resulted from docking. Similar to GTP
 

 
S, an established
late-acting inhibitor of the postdocking phase, both LPC-14
and -12 allowed trans-SNARE pairing (Fig. 4), albeit only up
to 50% of the uninhibited control. GTP
 

 
S permits docking as
well as lipid mixing. Thus, the levels of trans-SNARE pairing
reached in the presence of GTP
 

 
S should suffice to trigger
lipid mixing. To assay the correlation between trans-SNARE
pairing and fusion activity by independent means, we used
another, recently identified inhibitor of vacuole fusion, myris-
toylated alanine-rich C kinase substrate effector domain peptide
(MED; Fratti et al., 2004). MED sequesters phosphatidylinositol-
4,5-bisphosphate, binds calmodulin with a 
 
K
 
d
 
 of 4 nM, and
penetrates the acyl chain zone of lipid bilayers with its five
phenylalanines (Sundaram et al., 2004). All three effects could
contribute to its inhibitory activity in vacuole fusion. We ob-
served that MED strongly promoted mutual binding and cluster
formation of vacuoles (unpublished data). In accordance with
this, MED permitted SNARE pairing to at least the same levels
as in the uninhibited control, and in some experiments even
twofold more (Fig. 4 B). Nevertheless, MED blocked content
as well as lipid mixing (see next paragraph). Together, these re-
sults suggest that trans-SNARE complexes can efficiently form
in the absence of lipid mixing. Furthermore, they show that
LPCs and MED permit trans-SNARE association but interfere
with vacuole fusion downstream of docking.
 
LPC inhibits lipid mixing in vacuolar 
membrane fusion
 
To determine whether LPC inhibited merging of the membranes
or fusion pore formation, we used a novel assay for vacuolar
membrane fusion that detects the fusion-dependent flow of lip-
ids from one fusion partner to the other (Reese et al., 2005).
This assay is based on the concentration-dependent change in
fluorescence intensity of lissamine rhodamine B 1,2-dihexa-
decanoyl-sn-glycero-3-phosphoethanolamine (Rh-PE; rhodamine
dye coupled to dipalmitoyl-phosphatidylethanolamine). We in-
corporated self-quenching concentrations (3 mole percent) of
Rh-PE into the membranes of vacuoles isolated from one of our
standard fusion strains (DKY6281) and mixed them with a six-
fold excess of unlabeled vacuoles isolated from the other fusion
strain (BJ3505). Upon fusion, the labeled phospholipids are di-
luted into the unlabeled BJ3505 membrane, which increases the
relative fluorescence of rhodamine. Fusion reactions of identical
composition can be tested for content mixing via the common
vacuole fusion assay, which is based on the activation of pro-
ALP in BJ3505 vacuoles by processing proteases provided by
DKY6281 vacuoles. We titrated LPC-12 and MED into fusion
reactions to test in parallel how LPC influences lipid and content
mixing (Fig. 5). LPC-12 and MED inhibited both content- and
lipid-mixing signals to comparable degrees. Thus, LPC and
MED already suppress the lipid-mixing step of vacuolar mem-
brane fusion.
 
LPC blocks formation of V
 
0
 
 
trans-complexes
 
V
 
0
 
 sectors undergo a transformation in the final phase of vacuole
fusion, which can be diagnosed by the association of V
 
0
 
 sectors
from opposing membranes (Peters et al., 2001; Bayer et al.,
2003). V
 
0
 
–V
 
0
 
 association preferentially affects a population of
Figure 4. Trans-SNARE complex formation. Effects of LPC (A) and MED (B).
20 standard fusion reactions with vacuoles isolated from strains BJ3505
	vam3 and BJ3505 	nyv1 were started. Where indicated, the ATP-regen-
erating system was omitted and the sample was kept on ice. After 30
min, the reactions were stopped by chilling on ice. 380 l of precipitation
buffer was added (150 mM KCl, 1.3% [wt/vol] Triton X-100, 1.3 mM
PMSF, 1.2 PIC, and 13 mM EDTA in PS). Samples were shaken for 10
min at 4C and centrifuged at 21,000 g (10 min, 4C). 450 l of the sol-
ubilisate were transferred to a new reaction tube. 18 g of affinity-purified
anti-Vam3p antibody and 20 l of protein A–Sepharose CL-4B (GE
Healthcare) in 100 l of washing buffer (150 mM KCl, 1% [wt/vol] Triton
X-100, 1 mM PMSF, 1 PIC, and 10 mM EDTA in PS) were added to
each sample. After 1 h of shaking at 4C, the beads were washed with
precipitation buffer and resuspended in SDS sample buffer. Aliquots were
analyzed by SDS-PAGE and Western blotting. For A, trans-SNARE pairing
was quantified by densitometry and compared with fusion activity that
was determined from identical samples run in parallel (60 min, 27C).
The following inhibitors were used: 1 M Gdi1p, 500 M LPC-12, 120 M
LPC-14, 4 mM GTPS, and 10 M MED.
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V
 
0
 
 sectors associated with the vacuolar t-SNARE Vam3p. It is a
diagnostic criterion linked to the fusion cascade because it de-
pends on vacuole priming and docking and is sensitive to the
postdocking inhibitor BAPTA but insensitive to the latest acting
inhibitor of vacuole fusion, GTP
 

 
S. Lipid transition mapped to
the same stage as V
 
0
 
 transformation, i.e., it was insensitive to
GTP
 

 
S but sensitive to BAPTA (Reese et al., 2005). This sug-
gests that V
 
0
 
 transformation coincides with the induction of
lipid flow. If so, changing lipid bilayer conformation by LPC
might in turn influence V
 
0
 
 transformation. We tested the forma-
tion of V
 
0
 
 trans-complexes in the presence of LPCs or MED
(Fig. 6). Vacuoles were prepared from two strains carrying ei-
ther an HA or an AU tag on the V
 
0
 
 subunit Vph1p. The mem-
branes were incubated under fusion conditions in the presence
of various inhibitors. They were then solubilized, and Vph1p-HA
was precipitated with a monoclonal anti-HA antibody. Vph1p-AU
that was coimmunoprecipitated with Vph1p-HA was detected
by Western blotting against the AU tag. Without ATP, a condi-
tion preventing priming and docking, no Vph1p trans-association
was detected (Fig. 6 A). With ATP, Vph1p-AU coimmunopre-
cipitated with Vph1p-HA, indicating a stable association of the
proteins. Gdi1p, the docking inhibitor that prevents trans-
SNARE pairing, suppressed the formation of these V
 
0
 
–V
 
0
 
complexes as completely as MED. In contrast, GTP
 

 
S, which
inhibits after lipid mixing, permitted formation of V
 
0
 
 com-
plexes, although it reduced fusion by 
 


 
95%. In line with pre-
vious observations (Peters et al., 2001), this confirmed that the
V
 
0
 
–V
 
0
 
 complexes observed arose from trans-association of
V
 
0
 
–V
 
0
 
 sectors from two fusion partners before completion
of fusion. LPC prevented V
 
0
 
 trans-association (Fig. 6 A).
We also checked whether LPC destabilized an existing trans-
association of V
 
0
 
. To this end, we ran fusion reactions for 40
min in the presence of GTP
 

 
S to generate V
 
0
 
 trans-complexes.
LPC was added and, after 10 min of further incubation, the
vacuoles were solubilized and assayed for V
 
0
 
 trans-complexes.
The association of preformed V
 
0
 
 trans-complexes was only
slightly affected by subsequent addition of LPCs (Fig. 6 B),
demonstrating that LPCs do not destabilize V
 
0 trans-com-
plexes but interfere with their formation.
LPC arrests vacuole fusion at a 
productive intermediate state
Because LPCs reversibly incorporate into membranes, we tried
to rescue the fusion block by removing LPCs again (Cherno-
mordik et al., 1997; Melikyan et al., 2000). Fusion reactions
were started in the presence of LPC. After 40 min, LPC was
extracted from the membranes by floating the vacuoles through
fatty acid–free bovine serum albumin. New fusion reactions
were set up with these reisolated organelles and tested for their
sensitivities toward inhibitors (Fig. 7). Good fusion activity
was recovered after removing LPC. This shows that the vacu-
oles were not irreversibly damaged by LPC. Fusion after re-
versing the LPC block was insensitive to the docking inhibitor
Gdi1p, as expected from the kinetic analysis (Fig. 2) and the
docking assay (Fig. 4). The reaction stayed sensitive, however,
to the postdocking inhibitors BAPTA and GTPS. This indi-
cates that the LPC block is reversible, that the intermediate ac-
cumulating in the presence of LPC is productive, and that the
BAPTA- and GTPS-sensitive steps cannot be passed before
the LPC-sensitive stage.
Figure 5. Lipid mixing in the presence of LPC
and MED. (A and C) Fusion reactions with vac-
uoles containing rhodamine-labeled lipids
were set up. After addition of unlabeled ac-
ceptor vacuoles, fusion-dependent dilution of
the lipids was monitored via the increase in
relative fluorescence. Reactions were run in
the presence of control buffer or of LPC as
indicated. (B and D) Content mixing was as-
sayed from identical samples run in parallel.
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Fusion proceeds with similar rates from 
early and late intermediates
The availability of several reversible and late-acting inhibitors
enabled us to compare the kinetics of vacuole fusion after re-
lease from these blocks. Should an early subreaction be rate
limiting, a reaction arrested at a stage past this rate-limiting
event should proceed significantly faster than a standard reac-
tion. In contrast, if a late event in the reaction cascade is rate
limiting, a reaction rescued from arrest before or at this rate-
limiting step should run with a similar rate as an uninhibited
reaction. We determined fusion kinetics after release from re-
versible blocks. Fusion was started in the presence of the inhib-
itors to allow the vacuoles to proceed up to the targeted
reaction stage. Then the vacuoles were reisolated to remove the
inhibitors and used in new fusion reactions. After restarting the
reactions, aliquots were transferred to 0C in 10-min intervals
to stop further fusion and monitor the progress of the reaction.
We compared the fusion rates after release from postdocking
blocks with LPC, GTPS, and BAPTA to those of reactions
released from a high-salt block (250 mM KCl, which arrests
fusion at docking; unpublished data) and to a reaction without in-
hibitor, in which fusion had been prevented by omission of ATP.
MED was not used in this experiment because its inhibitory ef-
fect was not reversible by a simple washing of the membranes
(unpublished data). The rates after recovery from all reversible
blocks were similar to that of an uninhibited standard reaction
(Fig. 8). It appears unlikely that incomplete removal of the in-
hibitors after the block or slow dissociation of the inhibitors
from their targets could limit the fusion rate after rescue be-
cause the inhibitors are unrelated by chemical structure and by
mode of action. Therefore, the rate-limiting step of vacuole fu-
sion should lie at or beyond the stages sensitive to LPC,
BAPTA, and GTPS. Because docking and lipid flow between
the fusion partners occurs in the presence of GTPS (Reese et
al., 2005), our data suggests that the rate-limiting step in the fu-
sion pathway lies downstream of these events.
In sum, our results provide a basis to kinetically map the
requirement for lipid transition in the reaction sequence of vac-
uole fusion (Fig. 9). LPCs permit priming and docking. Lipid
conformation is crucial for the transition from docking to fu-
sion, i.e., to complete the BAPTA- and GTPS-sensitive steps
and to induce the conformational change of V0, which occurs
between docking and full fusion.
Discussion
Observations from this study can be integrated with previous
data to define the order of events in the postdocking phase of
vacuole fusion. LPC-blocked fusion reactions remain sensitive
to the fast-acting Ca2 chelator BAPTA and to GTPS, sug-
gesting that the LPC-sensitive step precedes events targeted by
Figure 6. V0 trans-complexes in the presence of LPC. (A) 15 standard
fusion reactions with cytosol were started using vacuoles from strains BJ
Vph1-HA and -AU and the indicated inhibitors. One sample did not con-
tain an ATP-regenerating system and was kept on ice. After 50 min, the
reactions were stopped by chilling on ice and adding 1 ml PS buffer.
Vacuoles were pelleted by centrifugation (21,000 g, 2 min, 4C). Pellets
were solubilized in 1.3 ml of precipitation buffer (150 mM KCl, 0.5 mM
MnCl2, 1% [wt/vol] Triton X-100, and 1 mM PMSF in PS), shaken for 5
min at 4C, and pelleted by centrifugation (21,000 g, 3 min, 4C). To 1.1
ml of the solubilisate, 5 l of monoclonal anti-HA antibody (raw ascites;
5–7 mg/ml) and 20 l of protein G–Agarose was added. After 1 h of
gentle shaking at 4C, samples were washed with precipitation buffer, sol-
ubilized in SDS sample buffer, and analyzed by SDS-PAGE and Western
blotting. (B) Stability of existing V0 trans-complexes against LPC-12. Fusion
reactions were run as in A but without LPC-12. 40 min after the start of
fusion, two of the samples (10) were supplemented with LPC-12 in order
to test the effect of LPC addition on V0 trans-complexes that had formed
during the first 40 min. All samples were incubated for another 10 min at
27C and then assayed for V0 trans-complexes as in A. The following
inhibitors were used: 1 M Gdi1p, 500 M LPC-12, 10 M MED, and
4 mM GTPS.
Figure 7. The fusion block with LPC is reversible. A 20 standard fusion
reaction was started in the presence of 450 M LPC-12. After 40 min at
27C, 800 l PS buffer with 15% (wt/vol) Ficoll and 0.5 mg/ml fatty acid–
free bovine serum albumin were added. 300 l PS buffer with 4% (wt/vol)
Ficoll and 400 l PS buffer were layered on top. Vacuoles were floated by
centrifugation (21,000 g, 5 min, 4C), recovered from the 0%/4% inter-
face, and assayed for protein content. The recovered vacuoles were used in
new standard fusion reactions with the indicated inhibitors. After 80 min,
fusion was assayed. Control fusion reactions that had not been blocked
with LPC and released were run in parallel. Their fusion activity was deter-
mined after 80 min at 27C. Four independent experiments were averaged.
Ice values had been subtracted. For the blocked and released reactions, ice
values varied from 0.58 to 0.97 U and fusion activities varied from 2.2 to
4.2 U. For the unblocked reactions, ice values varied from 0.2 to 0.35 U
and control values varied from 2.5 to 4.2 U. The following inhibitors were
used: 1 M Gdi1p, 5 mM BAPTA, and 4 mM GTPS.
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these two inhibitors. In turn, BAPTA-blocked vacuoles be-
come resistant to LPC. Trans-SNARE pairing is not prevented
by any of these three inhibitors. These data suggest that trans-
SNARE pairing is followed by an ordered sequence of steps
defined by sensitivities to LPC, BAPTA, and GTPS. Molecu-
lar events can now be grouped into this scheme: the transfor-
mation of V0, which is diagnosed by their capacity to form
V0–V0 trans-complexes; lipid transition by hemifusion; and fu-
sion pore opening and contents mixing. LPC (Figs. 5 and 6)
and BAPTA (Peters et al., 2001) block V0 transformation and
lipid transition between the fusion partners, whereas GTPS
permits these reactions and only blocks final opening of the fu-
sion pore (Reese et al., 2005). Thus, V0 transformation and
lipid flow kinetically map to the same stage between BAPTA
and GTPS. Because LPC and, by inference, bilayer conforma-
tion and spontaneous curvature influence V0 transformation, all
kinetic and molecular observations link V0 to the induction of
lipid transition.
When released from blocks with postdocking inhibitors,
vacuoles arrested by LPC, BAPTA, or GTPS completed fu-
sion with comparable kinetics as uninhibited reactions. This
strongly suggests that reactions blocked with either of the three
inhibitors still have to pass the rate-limiting step that seems to
be the same for all of them and hence should lie past the latest
acting of these inhibitors, GTPS. Several studies demonstrate
that the assay system is not rate limiting. The vacuolar content-
mixing assay requires activation of the lumenal pro-ALP by
two soluble proteases (Pep4p and Prb1p) from the other fusion
partner. A detailed study on the kinetics of pro-ALP conversion
by Pep4p and Prb1p (Merz and Wickner, 2004a) showed that
this step is not rate limiting in the in vitro fusion assay. Also, in
vivo mature ALP appears with a half time of 6 min (Klionsky
and Emr, 1989), which includes transport through the biosyn-
thetic pathway to the vacuole. Therefore, pro-ALP activation in
vacuoles takes much less than 6 min, and the rate-limiting pro-
cess must be inherent in the fusion cascade.
What could this rate-limiting step of fusion be? Theoretical
considerations (Chizmadzhev et al., 2000; Cohen and Melikyan,
2004) and experimental observations on influenza HA–mediated
fusion (Frolov et al., 2000; Markosyan et al., 2000) have sug-
gested that opening and expansion of a fusion pore rather than
induction of lipid transition may be the most energy demanding
step of fusion. In line with this, our observations place the rate-
limiting step past the GTPS-sensitive intermediate, i.e., at the
transition from lipid mixing to fusion pore opening (Reese et
al., 2005). This suggests that fusion pore opening rather than
trans-SNARE pairing or induction of lipid mixing is rate limit-
ing for vacuole fusion. Our results hence provide experimental
evidence from a physiological SNARE-dependent fusion system
that is consistent with the theoretical predictions postulating that
opening the pore may carry the highest cost of energy and be
rate limiting. With our current methodology, we could not dif-
ferentiate between substeps of fusion pore opening, e.g., the
opening of initial small pores and their expansion. Our content-
mixing assay requires transfer of an 40-kD protease and
hence measures a relatively large pore. It may not allow for
distinguishing very small initial pores, which could already
be observed in other systems (Breckenridge and Almers, 1987;
Zimmerberg et al., 1987, 1994; Curran et al., 1993; Lollike et
al., 1995; Chanturiya et al., 1997; Lindau and Alvarez de Toledo,
2003), from the final, fully expanded state.
Because both SNAREs and viral fusion proteins form
helical bundles, mechanistic parallels should be considered
(Chernomordik et al., 1997, 1998; Melikyan et al., 2000).
Type I viral fusion proteins fold back onto themselves and
form -helical bundles (Eckert and Kim, 2001; Park et al.,
2003). Formation of fully stabilized helical bundles need not
precede but can even follow lipid transition and the formation
of a fusion pore (Melikyan et al., 2000; Borrego-Diaz et al.,
2003; Markosyan et al., 2003). Complete helical bundle forma-
tion by viral fusion proteins hence does not correlate with
lipid mixing. It may rather assist in opening the fusion pore or
stabilize it after its formation. Lipid mixing is induced by the
membrane-perturbing activity of viral fusion peptides (Cherno-
Figure 8. Fusion kinetics after fusion block. Vacuoles were preincubated
under fusion conditions with 5 mM BAPTA, 4 mM GTPS, 420 M LPC-12,
and 250 mM KCl or without ATP-regenerating system for 40 min. Vacuoles
were then reisolated as in Fig. 7 and used to set up new fusion reactions
without inhibitors. Aliquots were removed every 10 min and set on ice.
After 80 min, fusion was assayed. Four independent experiments were
averaged. Measured ALP activities varied from 0.4 to 0.6 U for the 0-min
value and from 1.6 to 2.3 U for the 80-min value.
Figure 9. Working model of late subreactions in vacuolar membrane fusion.
SNAREs are initially found in cis-complexes in the same membrane com-
posed of v- and t-SNAREs (light and dark gray, respectively). They are dis-
assembled by the action of NSF/Sec18p and its cofactor -SNAP/
Sec17p during priming. Upon priming, Sec17p is released as soluble
protein. The action of several proteins leads to docking and the formation
of trans-SNARE complexes. LPC acts before the BAPTA-sensitive step. A late
subreaction involves conformational changes in the V0 sector of the vacuolar
ATPase, possibly resulting in lipid mixing. GTPS inhibits fusion down-
stream of V0 and lipid mixing.
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mordik and Kozlov, 2003; Tamm et al., 2003; Cohen and
Melikyan, 2004). SNAREs could act in a similar fashion, i.e.,
the helical bundle might serve to pin the membranes together
and assist in fusion pore opening once lipid transition has been
triggered by membrane-disturbing compounds.
Several observations are compatible with a role of
SNAREs in fusion pore formation. First, in artificial liposomes
the outcome of fusion depends on the density of SNAREs re-
constituted into their membranes (Lu et al., 2005; Xu et al.,
2005). Completion of fusion requires higher SNARE densities
and, by inference, higher densities of trans-SNARE complexes
than the induction of lipid flow. Second, flipped SNAREs ex-
pressed on the surface of cells can also mediate slow fusion of
such cells. If their transmembrane helices are replaced by gly-
cosylphosphatidylinositol anchors so that they cannot span the
entire bilayer, fusion pore opening is inefficient and hemifu-
sion becomes the frequent end state (Giraudo et al., 2005).
Also, truncation of the authentic transmembrane helix of
SNAREs favors hemifusion (Xu et al., 2005). That SNAREs
themselves might form part of the fusion pore was proposed
based on the observation that substitutions in the transmem-
brane anchors of t-SNAREs change the electrophysiological
properties of exocytic fusion pores measured in living cells
(Han et al., 2004). This was taken as an indication that the
transmembrane anchors of multiple SNAREs may form a bar-
rel that constitutes the initial fusion pore and dissociates upon
fusion pore expansion. However, biochemical evidence for the
existence of a SNARE barrel is still missing. The effects ob-
served are also consistent with other arrangements of SNAREs,
and the substitutions might influence the interaction of
SNAREs with other fusion-relevant proteins at exocytic sites,
of which there are many (Hong, 2005).
In contrast to the observations made mainly in liposome
systems with reconstituted SNAREs, which are consistent with
a direct role of SNAREs in fusion pore opening, other observa-
tions on physiological membrane systems are less compatible
with this view. Proteolytic removal of SNAREs on sea urchin
cortical vesicles does not abolish fusion if contact is estab-
lished by other means (Coorssen et al., 2003; Szule et al.,
2003). Alternatively, trans-SNARE complexes in this system
can also be disassembled by adding low concentrations of
Ca2. This does not prevent subsequent fusion either (Tahara et
al., 1998). Also, vacuolar trans-SNARE complexes were re-
ported to become dispensable for completing fusion from the
docked state (Ungermann et al., 1998b).
In the mechanochemical fusion model (Sollner, 2004),
trans-SNARE complexes were proposed to induce lipid mixing
by progressively zipping up from their membrane distal to their
membrane-proximal parts. An alternative hypothesis is that
they could already be fully zipped at the docking stage, mainly
pinning the membranes together but requiring other factors to
efficiently induce fusion. Several observations argue for the
latter model. First, in this study we observed that reduction or
enhancement of trans-SNARE pairing does not lead to compa-
rable reduction or enhancement of lipid mixing. Second, during
trans-SNARE complex formation in proteoliposomes, the entire
SNARE domains can pair in a single step, but fusion follows
complete core-complex formation with a long lag time (Zhang
et al., 2004). Third, in case of progressive helix zippering to-
ward the membrane anchors, one might expect competitive in-
hibition by peptides corresponding to the membrane-proximal
COOH-terminal part of the v-SNARE. This was not observed
(Melia et al., 2002), although analogous viral peptides could
block formation of the helical bundle (Eckert and Kim, 2001).
Finally, additional proteins are required for the transition from
trans-SNARE pairing to lipid mixing or complete vacuole fu-
sion, such as Vac8p (Wang et al., 2001) and V0 (Peters et al.,
2001; Bayer et al., 2003). Also, fusion of docked secretory ves-
icles in Drosophila melanogaster requires V0, as demonstrated
recently (Hiesinger et al., 2005).
LPC and the positive curvature of the membrane affect a
step past membrane docking and block subsequent transforma-
tion of V0 and lipid mixing. Therefore, we propose that docking
and lipid mixing are separable events in SNARE-dependent fu-
sion reactions. Trans-SNAREs may hold the membranes in
close proximity and possibly modify downstream factors, in
particular V0, which are required to trigger fusion. Such an in-
terpretation is consistent with the picture from viral fusion
where membrane apposition and fusion pore opening via heli-
cal bundles are separable from the induction of lipid mixing via
the fusion peptide (Qiao et al., 1999; Melikyan et al., 2000). In
both systems, the last step, opening the fusion pore, appears to
be the most demanding and rate-limiting event.
Materials and methods
LPC-8, LPC-10 (1-capryl-2-hydroxy-sn-glycero-3-phosphocholine), LPC-12
(1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine), and LPC-14 were pur-
chased from Avanti Polar Lipids, Inc. 20 mM of stock solutions of the LPCs
in PS buffer (200 mM sorbitol and 10 mM Pipes/KOH, pH 6.8) were
stored at 20C. Rh-PE was obtained from Invitrogen. Fatty acid–free bo-
vine serum albumin and analytical grade dimethyl sulfoxide were ob-
tained from Sigma-Aldrich. 3 mM Rh-PE stock solutions in DMSO were
stored at 20C. Production and purification of polyclonal antibodies to
Sec18p, Sec17p, Vam3p, and Nyv1p were described previously (Haas
and Wickner, 1996; Mayer et al., 1996; Nichols et al., 1997). Anti-HA
monoclonal mouse antibodies (raw ascites) and monoclonal mouse AU
antibodies were purchased from BaBCo. Monoclonal mouse antibody to
ALP was purchased from Invitrogen. Gdi1p was recombinantly expressed
and purified from Escherichia coli (Haas et al., 1995). GTPS was ob-
tained from Roche Molecular Biochemicals, and BAPTA was obtained
from Calbiochem. PS buffer was used as a basis for most solutions. MED
was produced by solid phase peptide synthesis and purified by HPLC.
Strains
BJ3505 and DKY6281 were the standard fusion strains. For the assay
of trans-SNARE pairing, we used deletion strains for Vam3p and Nyv1p
in BJ3505 (Nichols et al., 1997; Ungermann et al., 1998b). V0 trans-com-
plex formation was assayed with BJ3505 strains carrying either an AU
(SBY129) or an HA tag (SBY119) on Vph1p (Peters et al., 2001).
Vacuole isolation and fusion
Yeast was precultured in yeast extract/peptone/dextrose (YPD) medium
(6–8 h, 30C). Overnight cultures were inoculated (30C, 14–16 h; 225
rpm) in baffled 2-liter Erlenmeyer flasks with 1 liter of YPD medium. At an
OD600 of 2–5, cells were centrifuged (5 min, 4,000 g, 23C; JA10 rotor),
resuspended in 50 ml of 0.1 M Tris/Cl, pH 8.9, with 10 mM DTT, incu-
bated (10 min, 30C), centrifuged (5 min, 4,000 g, 2C; JA10 rotor), re-
suspended in 15 ml SB (50 mM potassium phosphate, pH 7.5, and 600
mM sorbitol in YPD with 0.2% dextrose and 3,600 U/ml oxalyticase for
BJ3505 and 1,800 U/ml for DKY6281), and transferred into 30-ml Corex
tubes. Cells were incubated (20 min, 30C), reisolated (1 min, 800 g,
then 1 min, 1,500 g, 2C; JA20 rotor), and resuspended in 2.5 ml of
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15% Ficoll 400 in PS buffer by gentle stirring with a glass rod. DEAE-dex-
tran (200 l for BJ3505 or 100 l for DKY6281) was added from 0.4
mg/ml of a fresh stock in 15% Ficoll in PS buffer. The cells were incubated
(2 min at 0C and 75 s at 30C), chilled again, transferred to a SW41
tube, and overlaid with 3 ml of 8% Ficoll, 3 ml of 4% Ficoll, and 1.5 ml of
0% Ficoll (all in PS buffer). After centrifugation (90 min, 150,000 g), the
vacuoles were harvested from the 0%/4% interphase. The amount of the
harvested 4% phase was minimized because it interferes with reisolation
of the vacuoles in subsequent experiments. A standard fusion reaction con-
tained 4 g of vacuoles, isolated from strains BJ3505 and DKY6281, in a
total volume of 31.5 l of reaction buffer (20 mM Pipes/KOH, pH 6.8,
200 mM sorbitol, 125 mM KCl, 0.5 mM MgCl2, 0.5 mM MnCl2, 0.5 mM
ATP, 7.5 M pefablock SC, 7.5 ng/ml leupeptin, 3.75 M o-phenanthro-
line, 37.5 ng/ml pepstatin A, 20 mM creatine phosphate, and 35 U/ml
creatine kinase). The ATP-regenerating system, containing MgCl2, ATP,
creatine phosphate, and creatine kinase, was added from a frozen 20
stock solution in PS buffer with 150 mM KCl. After 60 min at 27C, fusion
was assayed.
Content-mixing assay
Content mixing was determined via ALP activity. Mature ALP is generated
by transfer of proteinase A (contained in DKY6281 vacuoles) into BJ3505
vacuoles (carrying pro-ALP). After completion of the fusion reaction, vacu-
oles were lysed with 500 l of a mixture containing 1 mM p-nitrophenyl-
phosphate, 10 mM MgCl2, 0.5% (wt/vol) Triton X-100, and 250 mM
Tris/Cl, pH 8.9. After 4 min, 500 l of 1 M glycine, pH 11.5, was added
and the OD was read at 400 nm. 1 U of fusion activity is defined as 1
mol/l p-nitrophenol developed per minute and microgram of BJ3505
vacuoles at 27C. Ice values were subtracted.
Lipid-mixing assay
For the incorporation of Rh-PE into vacuolar membranes, 560 g of freshly
prepared vacuoles from strain DKY6281 were equilibrated in 800 l PS
buffer to 27C for 1.5 min, 60 l of 3 mM Rh-PE in DMSO were added
under mild vortexing, and vacuoles were reisolated. 500 l PS buffer con-
taining 15% (wt/vol) Ficoll were added and mixed. On top, 300 l PS
buffer containing 4% and 400 l PS buffer containing no Ficoll were lay-
ered. After centrifugation (5 min, 4C, 11,500 g), the labeled vacuoles
were recovered from the 4%/0% interface. 3 standard fusion reactions
contained a sixfold excess of unlabeled vacuoles from strain BJ3505 over
Rh-PE–labeled vacuoles isolated from strain DKY6281. For fluorescence
measurements, the reactions were transferred into black noncoated micro-
titerplates (Nunc). Rhodamine fluorescence was measured with a fluores-
cent plate reader (SpectraMax GeminiXS; Molecular Devices) at 538 nm
excitation and 585 nm emission. After completion of the reaction, the
membranes were solubilized by adding 100 l of 1% (wt/vol) Triton
X-100 in PS buffer. Fluorescence was followed for another 10 min with the
same settings as before, taking measurements every 30 s. The calculated
average of the measurement after addition of Triton X-100 served as the
fluorescence after infinite dilution (F(TX-100)). After addition of Triton
X-100, we measured 8,000 relative fluorescence units for all samples.
For the 0-min values, we measured 900 relative fluorescence units for all
samples. Measured fluorescence of a sample before solublization was
normalized to the fluorescence after infinite dilution, resulting in 	F/F(TX-
100) values. The resulting value for the 0-min time point was set to 0. Con-
tent mixing was measured in parallel samples via the established assay of
ALP activity. To this end, 31.5-l aliquots with an identical composition to
the ones measured in the fluorescent plate reader were incubated at 27C
for 70 min.
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